Evidence map›Paper›PMID 42436646›Full record

ReviewJournal of cellular physiology2026

Primary Cilia as Integrative Hubs of Metabolic Signaling in Type 2 Diabetes: Inter-Organ Evidence From Central, Peripheral, and Pancreatic Islet Tissues.

Meifang Liang, Chenxin Wen, Li Deng, Youqin Li, Fengru Lv, Zhengmin Feng, Ergan Li, Jingyi Li, Jiayu Zhou, Hai Liao and 2 more

Abstract readReview
In one paragraph

Review in Journal of cellular physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Meifang LiangCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.ORCID 0009-0006-8361-8675
Chenxin WenDepartment of Developmental & Regenerative Biology, Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
Li DengCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.
Youqin LiDepartment of General Surgery, The Center of Obesity and Metabolic Diseases, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.ORCID 0009-0007-8471-6880
Fengru LvCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.
Zhengmin FengCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.
Ergan LiDepartment of General Surgery, The Center of Obesity and Metabolic Diseases, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Jingyi LiCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.
Jiayu ZhouCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.
Hai LiaoCollege of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China.ORCID 0000-0002-1843-8444
Shanshan FengDepartment of Developmental & Regenerative Biology, Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
Zhonghui FengDepartment of General Surgery, The Center of Obesity and Metabolic Diseases, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.ORCID 0009-0007-5533-7144

Funding

Foundation of Chengdu Science and Technology Bureau 2024-YF05-01311-SNNational Natural Science Foundation of China 82202007National Natural Science Foundation of China NSFCNatural Science Foundation of Sichuan Province 2023NSFSC0739The Third People's Hospital of Chengdu Clinical Research Program 2023PI22
6 · The paper itself

Abstract

Primary cilia are highly specialized, solitary microtubule-based organelles widely present on the surface of mammalian cells. Acting as integrative platforms for membrane-associated signaling and intracellular pathways, primary cilia regulate Hedgehog (Hh), Wnt, G protein-coupled receptor (GPCR), and mTOR signaling and are closely implicated in metabolic dysregulation associated with type 2 diabetes (T2D). This review systematically summarizes current methodological approaches for studying primary cilia and delineates their pathogenic roles in T2D from multiple dimensions. In the central nervous system, hypothalamic primary cilia regulate appetite and energy expenditure through ADCY3/MC4R and BBSome modules. In peripheral metabolic organs, primary cilia in adipose tissue, liver, and bone influence cellular differentiation, lipid metabolism, and insulin sensitivity. In pancreatic islets, primary cilia on α, β, and δ cells coordinate hormone secretion and vascular remodeling via GPCR-cAMP, Somatostatin-SSTR3-GLI2, and Eph/Ephrin signaling pathways. Ciliopathy-associated genetic disorders and defects in centrosomal proteins further substantiate the pathological association between primary ciliary dysfunction and T2D. In addition, the identification of primary cilia-related biomarkers, together with therapeutic explorations involving MC4R agonists, GLP-1 receptor agonists, and mutation-targeted repair strategies, provides a rationale for the clinical translation of cilium-targeted interventions. Collectively, primary cilia may function as central hubs for integrating metabolic signals, regulating intercellular communication, and maintaining energy homeostasis. Future studies should further elucidate cell type-specific differences in primary ciliary receptor localization, signal integration, and secretory regulation; clarify the temporal dynamics of primary ciliary function during development, metabolic stress, and disease progression; and evaluate the structural and functional plasticity of primary cilia, as well as potential therapeutic windows, to facilitate the translation of cilia biology from mechanistic insights to clinical applications in T2D.

Indexed as

CiliaDiabetes Mellitus, Type 2Islets of LangerhansAnimalsEnergy MetabolismHumansReceptors, G-Protein-CoupledSignal TransductionReceptors, G-Protein-Coupledenergy homeostasisinter‐organ signalingmetabolic regulationprimary ciliaT2D

Identifiers

PMID42436646
PMCPMC13356578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.